Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Specific Antigens”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05533047
What this trial is testing

Serum Prostatic Specific Antigen Changes After Bipolar and Monopolar TURP

Who this might be right for
PSA Changes After TURP
Assiut University 2
Testing effectiveness (Phase 2)Study completedNCT01046916
What this trial is testing

Safety and Efficacy Study of TAK-700 in Patients With Nonmetastatic Castration-resistant Prostate Cancer and a Rising Prostate-specific Antigen

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 38
Not applicableStudy completedNCT05522257
What this trial is testing

PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell Carcinomas

Who this might be right for
Sarcoma,Soft TissueUrothelial Carcinoma
Leiden University Medical Center 25
Early research (Phase 1)Study completedNCT00712829
What this trial is testing

Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents

Who this might be right for
Prostate Cancer
Molecular Insight Pharmaceuticals, Inc. 12
Large-scale testing (Phase 3)Ended earlyNCT00514917
What this trial is testing

Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)

Who this might be right for
Prostatic Neoplasms
Sanofi 413
Not applicableUnknownNCT06241391
What this trial is testing

Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas

Who this might be right for
GliomaAstrocytomaAnaplastic Astrocytoma+2 more
All India Institute of Medical Sciences, Bhubaneswar 35
Large-scale testing (Phase 3)Active Not RecruitingNCT05794906
What this trial is testing

Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

Who this might be right for
Biochemically Recurrent Prostate Cancer
Bayer 985
Large-scale testing (Phase 3)Looking for participantsNCT07052214
What this trial is testing

PSMA PET Combined With MRI for the Detection of PCa

Who this might be right for
PCAProstate CancerProstatic Neoplasm+6 more
Telix Pharmaceuticals (Innovations) Pty Limited 338
Testing effectiveness (Phase 2)Active Not RecruitingNCT05849298
What this trial is testing

A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC

Who this might be right for
Prostatic Neoplasm
Novartis Pharmaceuticals 49
Testing effectiveness (Phase 2)Study completedNCT01856933
What this trial is testing

BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)

Who this might be right for
GBMGlioblastoma MultiformeGliosarcoma
Heinrich Elinzano, MD 6
Testing effectiveness (Phase 2)Study completedNCT01302041
What this trial is testing

Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy

Who this might be right for
Prostate Cancer
Astellas Pharma Inc 67
Not applicableEnrolling By InvitationNCT03423303
What this trial is testing

Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen)

Who this might be right for
Prostate Cancer
Tampere University 17,400
Not applicableUnknownNCT04599699
What this trial is testing

Integrated Boost to the Dominant Intraprostatic Nodule Based on Ga-68 PSMA PET/MR Study of SBRT With Prostate Cancer

Who this might be right for
Treatment
Changhai Hospital 20
Testing effectiveness (Phase 2)Study completedNCT04936334
What this trial is testing

The Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate Cancer

Who this might be right for
Prostate Cancer
Clinton Bahler 51
Testing effectiveness (Phase 2)Study completedNCT00450463
What this trial is testing

Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Study completedNCT05670106
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 62
Early research (Phase 1)Study completedNCT06101927
What this trial is testing

Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413

Who this might be right for
Prostate Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 10
Not applicableNot Yet RecruitingNCT06900348
What this trial is testing

Prostate Specific Antigen Levels of Individuals Living in Rural Areas

Who this might be right for
Prostate Carcinoma
Suleyman Demirel University 308
Not applicableStudy completedNCT00490763
What this trial is testing

Active Surveillance in Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 1,139
Not applicableStudy completedNCT03704389
What this trial is testing

Behavioral Economics Applications to Geriatrics Leveraging EHRs

Who this might be right for
Prostate Specific AntigenAsymptomatic BacteriuriaType 2 Diabetes Mellitus
Northwestern University 664
Next Page